News | January 04, 2011

FDA Forecasts Medical Device Technology Trends for Next Decade

January 4, 2010 – The U.S. Food and Drug Administration (FDA) has released an update of what medical devices it expects to be developed and brought to market within the next 10 years.

The FDA this week released its “Future Trends in Medical Device Technologies” from the William A. Herman and Gilbert B. Devey Center for Devices and Radiological Health (CDRH). The forecast reflects the inputs of many participants, including senior CDRH technical managers and 15 non-FDA experts, including physicians, engineers, healthcare policymakers, manufacturers and technology analysts.

The study found the following technologies have a high likelihood of being developed and making it to market in the next decade:

Computerized devices and medical IT systems
- Integrated electronic patient medical records
- Computer-assisted diagnostic systems
- Internet-based medical device systems
- Virtual reality systems for immersive training and other applications
- Networks and systems of devices

Robotic products and systems
- Robotic surgical systems
- Robotic prosthetics

Wireless products and systems
- Advanced radiofrequency identification (RFID) systems

Artificial organs and organ-assistive products
- Tissue engineered products
- Neuro-sensory devices
- Glucose monitoring products
- Electrostimulation products
- New types of insulin pumps and delivery systems
- Advanced prosthetic limbs
- New types of stents
- Joint replacements

Combination device and drug/biological products
- New (non-eluting) drug delivery systems

Imaging devices and systems
- Image-guided therapy systems
- Advanced ultrasound imaging systems
- Advanced optical imaging systems
- Advanced magnetic resonance (MR) imaging systems

Photonic products
- Optical diagnostic products
- Optical therapeutic devices

Minimally invasive therapeutic products
- Minimally invasive implants (e.g., percutaneous or natural orifice delivery)
- Minimally invasive radiotherapy systems

Home- and self-care products
- New types of home sensors
- Smart homes

Aging-related products

Genomic, proteomic, metabolomic, and epigenomic technologies
- Genetic diagnostic products

Sensor technologies
- New sensors

Patient monitoring systems
- Remote patient monitoring systems

Other
- Point-of-care products
- MEMS/MOTES devices

The primary purpose of the forecast is to help CDRH (and other medical device stakeholders) prepare for pioneering products that will pose new scientific questions and regulatory issues during the next decade. This preview it provides is intended to help CDRH develop initiatives to identify key scientific issues, collect basic information and set clear regulatory strategies for responding to a flow of new products. To these ends, the forecast identifies emerging medical device technologies and types of devices that manufacturers are highly likely to submit to CDRH for premarket decision making.

For a copy of the complete report: www.fda.gov/downloads/AboutFDA/CentersOffices/CDRH/CDRHReports/UCM238527.pdf

Related Content

News | Cardiovascular Surgery

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking ...

Home April 29, 2022
Home
News | Cardiovascular Surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
News | Cardiovascular Surgery
February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA ...
Home February 15, 2022
Home
News | Cardiovascular Surgery

February 11, 2022 — Riverside Community Hospital has earned a distinguished three-star rating from The Society of ...

Home February 11, 2022
Home
News | Cardiovascular Surgery

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

Home November 23, 2021
Home
News | Cardiovascular Surgery

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

Home November 22, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

Home November 18, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

Home November 18, 2021
Home
Feature | Cardiovascular Surgery | By Noam Emanuel, Ph.D.

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be ...

Home June 24, 2021
Home
News | Cardiovascular Surgery

April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...

Home April 05, 2021
Home
Subscribe Now